US Stock MarketDetailed Quotes

TRAW Traws Pharma

Watchlist

1.450
+0.020+1.40%

Close Apr 30 16:00 ET

7.73MMarket Cap-0.04P/E (TTM)

Traws Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

Assets

Current assets

Cash, cash equivalents and short term investments

2.48%21.34M

-78.57%5.41M

-43.20%16.89M

-52.10%16.39M

-46.28%20.82M

-40.76%25.24M

-36.11%29.73M

-32.59%34.22M

-Cash and cash equivalents

2.48%21.34M

-78.57%5.41M

-43.20%16.89M

-52.10%16.39M

-46.28%20.82M

-40.76%25.24M

-36.11%29.73M

-32.59%34.22M

Receivables

9,705.56%1.77M

11,683.33%2.12M

5.88%18K

-37.93%18K

-35.71%18K

-39.29%17K

-37.04%17K

-Accounts receivable

9,705.56%1.77M

11,683.33%2.12M

5.88%18K

-37.93%18K

-35.71%18K

-39.29%17K

-37.04%17K

Prepaid assets

17.61%1.67M

-27.73%1.05M

169.09%1.18M

101.91%1.48M

172.55%1.42M

79.18%1.45M

-62.26%440K

164.98%734K

Other current assets

-55.61%178K

14.52%347K

120.83%583K

286.76%263K

902.50%401K

0.00%303K

-13.73%264K

-77.78%68K

Total current assets

10.11%24.95M

-66.97%8.92M

-38.68%18.67M

-48.19%18.15M

-42.41%22.66M

-38.26%27.01M

-36.61%30.45M

-31.80%35.04M

Non current assets

Net PPE

-54.55%10K

-53.85%12K

-17.65%14K

-14.29%18K

-8.33%22K

-7.14%26K

-45.16%17K

-40.00%21K

-Gross PPE

0.00%84K

20.00%84K

0.00%70K

-Accumulated depreciation

-19.35%-74K

-24.14%-72K

-32.08%-70K

-34.69%-66K

-34.78%-62K

-38.10%-58K

-35.90%-53K

-40.00%-49K

Other non current assets

0.00%1K

-90.00%1K

Total non current assets

-52.17%11K

-51.85%13K

-16.67%15K

-13.64%19K

-8.00%23K

-6.90%27K

-56.10%18K

-51.11%22K

Total assets

10.05%24.96M

-66.95%8.94M

-38.67%18.69M

-48.17%18.17M

-42.39%22.68M

-38.24%27.04M

-36.62%30.47M

-31.82%35.06M

Liabilities

Current liabilities

Payables

45.68%8.19M

-11.00%5.47M

21.75%6.17M

34.15%6.57M

45.57%5.62M

63.51%6.15M

68.86%5.07M

56.82%4.9M

-accounts payable

45.68%8.19M

-11.00%5.47M

21.75%6.17M

34.15%6.57M

45.57%5.62M

63.51%6.15M

68.86%5.07M

56.82%4.9M

Current accrued expenses

20.35%2.86M

-20.48%1.95M

18.73%3.12M

-36.24%2.17M

-14.42%2.37M

4.49%2.45M

20.67%2.63M

81.79%3.41M

Current deferred liabilities

0.00%226K

0.44%227K

0.00%226K

Current liabilities

25.09%11.53M

-13.71%8.35M

14.35%9.91M

2.15%9.42M

14.59%9.22M

31.87%9.67M

34.15%8.67M

55.08%9.22M

Non current liabilities

Non current deferred liabilities

-8.10%2.57M

-7.94%2.62M

-7.82%2.68M

-7.63%2.74M

-7.49%2.79M

-7.35%2.85M

-7.22%2.9M

-7.09%2.96M

Derivative product liabilities

--42.49M

----

--0

----

Preferred securities outside stock equity

----

--111.62M

----

Total non current liabilities

1,514.44%45.06M

-7.94%2.62M

3,835.81%114.3M

-7.63%2.74M

-7.49%2.79M

-7.35%2.85M

-7.22%2.9M

-7.09%2.96M

Total liabilities

371.17%56.59M

-12.40%10.97M

973.52%124.21M

-0.23%12.16M

8.57%12.01M

20.29%12.52M

20.65%11.57M

33.39%12.19M

Shareholders'equity

Share capital

300.00%36K

-85.71%30K

20.48%253K

0.48%211K

-95.69%9K

0.48%210K

-common stock

300.00%36K

-85.71%30K

20.48%253K

0.48%211K

-95.69%9K

0.48%210K

-Preferred stock

--0

----

--0

Retained earnings

-34.50%-649.15M

-29.43%-619.23M

-28.93%-610.76M

-3.87%-487.61M

-4.09%-482.63M

-4.40%-478.45M

-4.60%-473.71M

-4.59%-469.46M

Paid-in capital

25.18%617.53M

25.25%617.2M

2.56%505.02M

0.26%493.45M

0.31%493.32M

0.26%492.78M

0.25%492.42M

0.25%492.15M

Gains losses not affecting retained earnings

-82.61%-42K

-10.00%-33K

-17.86%-33K

-11.11%-30K

30.30%-23K

50.82%-30K

31.71%-28K

-28.57%-27K

Total stockholders'equity

-396.38%-31.63M

-114.00%-2.03M

-658.37%-105.52M

-73.71%6.02M

-62.30%10.67M

-56.50%14.52M

-50.89%18.9M

-45.90%22.88M

Total equity

-396.38%-31.63M

-114.00%-2.03M

-658.37%-105.52M

-73.71%6.02M

-62.30%10.67M

-56.50%14.52M

-50.89%18.9M

-45.90%22.88M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments	2.48%21.34M	2.48%21.34M	-78.57%5.41M	-43.20%16.89M	-52.10%16.39M	-46.28%20.82M	-46.28%20.82M	-40.76%25.24M	-36.11%29.73M	-32.59%34.22M
-Cash and cash equivalents	2.48%21.34M	2.48%21.34M	-78.57%5.41M	-43.20%16.89M	-52.10%16.39M	-46.28%20.82M	-46.28%20.82M	-40.76%25.24M	-36.11%29.73M	-32.59%34.22M
Receivables	9,705.56%1.77M	9,705.56%1.77M	11,683.33%2.12M	5.88%18K	5.88%18K	-37.93%18K	-37.93%18K	-35.71%18K	-39.29%17K	-37.04%17K
-Accounts receivable	9,705.56%1.77M	9,705.56%1.77M	11,683.33%2.12M	5.88%18K	5.88%18K	-37.93%18K	-37.93%18K	-35.71%18K	-39.29%17K	-37.04%17K
Prepaid assets	17.61%1.67M	17.61%1.67M	-27.73%1.05M	169.09%1.18M	101.91%1.48M	172.55%1.42M	172.55%1.42M	79.18%1.45M	-62.26%440K	164.98%734K
Other current assets	-55.61%178K	-55.61%178K	14.52%347K	120.83%583K	286.76%263K	902.50%401K	902.50%401K	0.00%303K	-13.73%264K	-77.78%68K
Total current assets	10.11%24.95M	10.11%24.95M	-66.97%8.92M	-38.68%18.67M	-48.19%18.15M	-42.41%22.66M	-42.41%22.66M	-38.26%27.01M	-36.61%30.45M	-31.80%35.04M
Non current assets
Net PPE	-54.55%10K	-54.55%10K	-53.85%12K	-17.65%14K	-14.29%18K	-8.33%22K	-8.33%22K	-7.14%26K	-45.16%17K	-40.00%21K
-Gross PPE	0.00%84K	0.00%84K	0.00%84K	20.00%84K	20.00%84K	20.00%84K	20.00%84K	20.00%84K	0.00%70K	0.00%70K
-Accumulated depreciation	-19.35%-74K	-19.35%-74K	-24.14%-72K	-32.08%-70K	-34.69%-66K	-34.78%-62K	-34.78%-62K	-38.10%-58K	-35.90%-53K	-40.00%-49K
Other non current assets	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	0.00%1K	-90.00%1K	-90.00%1K
Total non current assets	-52.17%11K	-52.17%11K	-51.85%13K	-16.67%15K	-13.64%19K	-8.00%23K	-8.00%23K	-6.90%27K	-56.10%18K	-51.11%22K
Total assets	10.05%24.96M	10.05%24.96M	-66.95%8.94M	-38.67%18.69M	-48.17%18.17M	-42.39%22.68M	-42.39%22.68M	-38.24%27.04M	-36.62%30.47M	-31.82%35.06M
Liabilities
Current liabilities
Payables	45.68%8.19M	45.68%8.19M	-11.00%5.47M	21.75%6.17M	34.15%6.57M	45.57%5.62M	45.57%5.62M	63.51%6.15M	68.86%5.07M	56.82%4.9M
-accounts payable	45.68%8.19M	45.68%8.19M	-11.00%5.47M	21.75%6.17M	34.15%6.57M	45.57%5.62M	45.57%5.62M	63.51%6.15M	68.86%5.07M	56.82%4.9M
Current accrued expenses	20.35%2.86M	20.35%2.86M	-20.48%1.95M	18.73%3.12M	-36.24%2.17M	-14.42%2.37M	-14.42%2.37M	4.49%2.45M	20.67%2.63M	81.79%3.41M
Current deferred liabilities	0.00%226K	0.00%226K	0.00%226K	0.44%227K	0.00%226K	0.00%226K	0.00%226K	0.00%226K	0.00%226K	0.00%226K
Current liabilities	25.09%11.53M	25.09%11.53M	-13.71%8.35M	14.35%9.91M	2.15%9.42M	14.59%9.22M	14.59%9.22M	31.87%9.67M	34.15%8.67M	55.08%9.22M
Non current liabilities
Non current deferred liabilities	-8.10%2.57M	-8.10%2.57M	-7.94%2.62M	-7.82%2.68M	-7.63%2.74M	-7.49%2.79M	-7.49%2.79M	-7.35%2.85M	-7.22%2.9M	-7.09%2.96M
Derivative product liabilities	--42.49M	--42.49M	----	----	----	--0	--0	----	----	----
Preferred securities outside stock equity	----	----	----	--111.62M	----	----	----	----	----	----
Total non current liabilities	1,514.44%45.06M	1,514.44%45.06M	-7.94%2.62M	3,835.81%114.3M	-7.63%2.74M	-7.49%2.79M	-7.49%2.79M	-7.35%2.85M	-7.22%2.9M	-7.09%2.96M
Total liabilities	371.17%56.59M	371.17%56.59M	-12.40%10.97M	973.52%124.21M	-0.23%12.16M	8.57%12.01M	8.57%12.01M	20.29%12.52M	20.65%11.57M	33.39%12.19M
Shareholders'equity
Share capital	300.00%36K	300.00%36K	-85.71%30K	20.48%253K	0.48%211K	-95.69%9K	-95.69%9K	0.48%210K	0.48%210K	0.48%210K
-common stock	300.00%36K	300.00%36K	-85.71%30K	20.48%253K	0.48%211K	-95.69%9K	-95.69%9K	0.48%210K	0.48%210K	0.48%210K
-Preferred stock	--0	--0	--0	----	--0	--0	--0	--0	--0	--0
Retained earnings	-34.50%-649.15M	-34.50%-649.15M	-29.43%-619.23M	-28.93%-610.76M	-3.87%-487.61M	-4.09%-482.63M	-4.09%-482.63M	-4.40%-478.45M	-4.60%-473.71M	-4.59%-469.46M
Paid-in capital	25.18%617.53M	25.18%617.53M	25.25%617.2M	2.56%505.02M	0.26%493.45M	0.31%493.32M	0.31%493.32M	0.26%492.78M	0.25%492.42M	0.25%492.15M
Gains losses not affecting retained earnings	-82.61%-42K	-82.61%-42K	-10.00%-33K	-17.86%-33K	-11.11%-30K	30.30%-23K	30.30%-23K	50.82%-30K	31.71%-28K	-28.57%-27K
Total stockholders'equity	-396.38%-31.63M	-396.38%-31.63M	-114.00%-2.03M	-658.37%-105.52M	-73.71%6.02M	-62.30%10.67M	-62.30%10.67M	-56.50%14.52M	-50.89%18.9M	-45.90%22.88M
Total equity	-396.38%-31.63M	-396.38%-31.63M	-114.00%-2.03M	-658.37%-105.52M	-73.71%6.02M	-62.30%10.67M	-62.30%10.67M	-56.50%14.52M	-50.89%18.9M	-45.90%22.88M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--